TickerFacts.

Minerva Neurosciences, Inc. (NERV): Capital Expenditures

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Capital Expenditures is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$16.3K
Year ended 2022-12-31
-20.8%
5-year compound annual growth
$52.4K2013-12-31: $3.2K2014-12-31: $45.6K2017-12-31: $52.4K2022-12-31: $16.3K$16.3K
2013-12-31 Capital Expenditures (USD) 2022-12-31
Period endedCapital ExpendituresChange YoYSource filing
2022-12-31$16.3Kn/a2024-02-22, From 2022-01-01
No annual figure between 2017-12-31 and 2022-12-31.
2017-12-31$52.4Kn/a2019-03-12, From 2017-01-01
No annual figure between 2014-12-31 and 2017-12-31.
2014-12-31$45.6Kn/m2017-03-13, From 2014-01-01
2013-12-31$3.2Kn/a2015-03-26, From 2013-01-01